Heavy cervical cancer burden in elderly women: How can we improve the situation?

Acta Cytologica

Volumn 56, Issue 4, 2012, Pages 388-393

  Skaznik Wikiel, Malgorzata E ^a   Sukumvanich, Paniti ^a   Austin, R Marshall ^a   Zorn, Kristin K ^a   Krivak, Thomas C ^a   Edwards, Robert P ^a   Olawaiye, Alexander B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cervical cancer; Elderly women; Incidence; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; ELDERLY CARE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 84864200826     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000338555     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J, et al: International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int J Cancer 2000;86:429-435.
3. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
4. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK: SEER Cancer Statistics Review 1973-1997. Bethesda, National Cancer Institute, 2000.
5. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK: SEER Cancer Statistics Review 1975-2004. Bethesda, National Cancer Institute, 2007.
6. Chan PK, Chang AR, Yu MY, Li WH, Chan MY, Yeung AC, et al: Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer 2010;126:297-301.
7. US Preventive Services Task Force: Screening for cervical cancer: recommendations and rationale. Am J Nurs 2003;103:101-102, 105-106, 108-109.
8. ACOG Committee on Practice Bulletins - Gynecology: ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet Gynecol 2009;114:1409-1420.
9. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al: American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
10. Hartmann KE, Hall SA, Nanda K, Boggess JF, Zolnoun D: Screening for Cervical Cancer. Systematic Evidence Review No. 25. Rockville, Agency for Healthcare Research and Quality, 2002.
11. Shrestha L: Life expectancy in the United States. CRS Report for Congress, 2006.
12. National Institutes of Health: Cervical cancer. NIH consensus statement 1996;14:1-38.
13. MacDonald CF: Assessing secondary prevention methods for cervical cancer: costs and benefits in managed care. Am J Manag Care 2008;14:S185-S192.
14. Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, et al: Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Nat Cancer Inst 2005;97:675-683.
15. Eggleston KS, Coker AL, Luchok KJ, Meyer TE: Adherence to recommendations for followup to abnormal Pap tests. Obstet Gynecol 2007;109:1332-1341.
16. Sawaya GF, Sung HY, Kearney KA, Miller M, Kinney W, Hiatt RA, et al: Advancing age and cervical cancer screening and prognosis. J Am Geriatr Soc 2001;49:1499-504.
17. Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, et al: Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer 2005;103:85-91.
18. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK: SEER Cancer Statistics Review 1973-1996. Bethesda, National Cancer Institute, 1999.
19. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
20. Sawaya GF, Brown AD, Washington AE, Garber AM: Clinical practice: current approaches to cervical-cancer screening. New Engl J Med 2001;344:1603-1607.
21. Roberts AD, Denholm RB, Cordiner JW: Cervical intraepithelial neoplasia in postmenopausal women with negative cervical cytology. Br Med J (Clin Res Ed) 1985;290:281.
22. Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM: Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Cancer 2007;111:292-297.
23. Hewitt M, Devesa SS, Breen N: Cervical cancer screening among U. S. women: analyses of the 2000 National Health Interview Survey. Prev Med 2004;39:270-278.
24. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC: Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-1540.
25. Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM, et al: Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 1999;180:571-577.
26. Mandelblatt J, Lawrence W, Yi B, King J: The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening. Arch Intern Med 2004;164:245-248.
27. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-2381.
28. Ronco G, Sideri MG, Ciatto S: Cervical intraepithelial neoplasia and higher long term risk of cancer. BMJ 2007;335:1053-1054.
29. Zhao C, Austin RM: Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone. Gynecol Oncol 2007;107:231-235.
30. Zhao C, Austin RM: Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample. Cancer 2008;114:242-248.